Presse & Publikationen
Ausgewählte Presseberichte & Interviews
PRESS & PUBLICATIONS
Selected Press Reports
& Interviews
ÄRZTE KRONE, 2024
The treatment of Parkinson’s disease is constantly evolving: modern therapy concepts aim to avoid motor complications such as “off” phases and dyskinesia for as long as possible. This specialist article in Ärzte Krone highlights current findings on diagnosis, progression, and individual therapy options.
KRONEN ZEITUNG, 2021
Even in advanced stages of Parkinson’s, a wide range of therapy options is available today. Modern medications, pump systems, or deep brain stimulation can help significantly improve mobility and quality of life. This feature in Krone Gesundheit showcases current treatment options and offers encouragement to those affected.
DIE PRESSE, 2009
Parkinson’s disease often appears gradually and is not always recognized immediately. A personal report from clinical practice sheds light on diagnosis, progression, and modern therapy options—emphasizing the importance of early treatment, exercise, and support for the patient’s quality of life and autonomy.
DER STANDARD, 2012
Approximately 20,000 people in Austria suffer from Parkinson’s disease. The condition starts insidiously and often remains unnoticed for a long period.
DIE PRESSE, 2012
Neurology: Initial symptoms can appear up to ten years before the clinical outbreak of the disease. Research, therefore, focuses on early detection and rapid therapy. There are approximately 20,000 affected individuals in Austria.
DER STANDRAD, 2015
Parkinson’s is a chronic disease with many facets. Neurologist Willi Gerschlager explains how modern medications secure quality of life.
DER STANDRAD, 2016
18,000 people in Austria suffer from Parkinson’s, and the number is expected to double by 2050, according to neurologist Willibald Gerschlager.
DER STANDRAD, 2019
Physicians predict that the number of patients will double by 2036. New therapeutic approaches provide grounds for hope. April 11th marks World Parkinson’s Day.
KRONEN ZEITUNG, 2025
The symptoms of the chronic neurological condition Parkinson’s can usually be well-controlled for many years with oral medications (e.g.,
Levodopa). As the disease progresses and fluctuations in effectiveness occur, this becomes increasingly difficult—but effective solutions are available.